17.2 Clinical Measurements & Intensive Care Monitoring: Cardiac Output, Arterial Blood Gases & Pulmonary Functions

Hemodynamic Physiology & Cardiac Output Measurement Modalities

Accurate assessment of cardiovascular performance is a cornerstone of intensive care and perioperative medicine. Cardiac output (CO) reflects global tissue perfusion and oxygen delivery (DO2).

Fundamental Hemodynamic Formulas

1. Cardiac Output (CO) & Cardiac Index (CI):

   • Cardiac Output: CO = HR × SV (Normal: 4.0 to 8.0 L/min)
   • Cardiac Index: CI = CO / BSA (Normal: 2.5 to 4.0 L/min/m²)
   • A CI < 2.0 L/min/m² indicates low output; cardiogenic shock requires evidence of tissue hypoperfusion due to cardiac dysfunction.

2. Stroke Volume Index (SVI):

   • SVI = SV / BSA (Normal: 33 to 47 mL/beat/m²)

3. Mean Arterial Pressure (MAP):

   • MAP = DBP + 1/3(SBP - DBP) = (SBP + 2 × DBP) / 3 (Normal: 70 to 105 mmHg)
   • An initial MAP target around 65 mmHg is common in adult shock; adjust it to the clinical context and evidence of organ perfusion.

4. Systemic Vascular Resistance (SVR):

   • SVR = [(MAP - CVP) / CO] × 80 (Normal: 800 to 1200 dynes·s/cm⁵)
   • Multiplying by 80 converts the hybrid pressure-flow units (mmHg·min/L) into absolute CGS physical units (dynes·s/cm⁵).

5. Pulmonary Vascular Resistance (PVR):

   • PVR = [(MPAP - PAWP) / CO] × 80 (Normal: 100 to 250 dynes·s/cm⁵)

---

The Direct Fick Principle: Gold Standard Mass Conservation

The Fick principle, formulated by Adolf Fick in 1870, represents the historical and biological gold standard for cardiac output determination based upon the conservation of mass. It states that the total uptake of a marker substance (oxygen) by an organ (the lungs) must equal the product of blood flow through the organ (cardiac output) and the concentration difference of that marker across the organ (arteriovenous oxygen content difference):

VO2 = CO × (CaO2 - CvO2)

Rearranging to solve for Cardiac Output (CO):

CO = VO2 / (CaO2 - CvO2) = VO2 / [(1.34 × Hb × SaO2) - (1.34 × Hb × SvO2)]

Where:

• VO2: Whole-body oxygen consumption in mL O2/min (measured directly via indirect calorimetry or metabolic hood; normal ~200-250 mL/min, or ~3.5 mL/kg/min).
• CaO2: Arterial oxygen content in mL O2/dL (obtained from arterial line sample).
• CvO2: Mixed venous oxygen content in mL O2/dL (obtained from a pulmonary artery catheter sample; true mixed venous blood requires sampling from the pulmonary artery where superior vena cava, inferior vena cava, and coronary sinus blood are completely blended).
• 1.34: Hüfner's constant (mL of O2 bound per gram of fully saturated hemoglobin; dissolved oxygen 0.003 × PO2 contributes < 0.3 mL/dL and is clinically negligible at room air).

Step-by-Step Worked Clinical Fick Calculation

Clinical Scenario: A 60-year-old male with severe ischemic cardiomyopathy is evaluated in the cardiac catheterization laboratory. His measured parameters are:

• Hemoglobin (Hb) = 15.0 g/dL
• Measured Oxygen Consumption (VO2) = 250 mL/min
• Arterial Oxygen Saturation (SaO2) = 98% (0.98)
• Mixed Venous Oxygen Saturation (SvO2) from pulmonary artery = 73% (0.73)
• Body Surface Area (BSA) = 1.80 m²

Step 1: Calculate Arterial Oxygen Content (CaO2):

• CaO2 = 1.34 × 15.0 × 0.98 = 19.70 mL O2/dL = 197.0 mL O2/L

Step 2: Calculate Mixed Venous Oxygen Content (CvO2):

• CvO2 = 1.34 × 15.0 × 0.73 = 14.67 mL O2/dL = 146.7 mL O2/L

Step 3: Calculate Arteriovenous Oxygen Content Difference (CaO2 - CvO2):

• CaO2 - CvO2 = 197.0 - 146.7 = 50.3 mL O2/L (or 5.03 mL O2/dL)

Step 4: Compute Cardiac Output (CO):

• CO = VO2 / (CaO2 - CvO2) = 250 mL/min / 50.3 mL/L = 4.97 L/min

Step 5: Compute Cardiac Index (CI):

• CI = 4.97 L/min / 1.80 m² = 2.76 L/min/m² (Normal)

---

Pulmonary Artery Catheterization & Shock Hemodynamics

The Pulmonary Artery Catheter (PAC; Swan-Ganz catheter) is a flow-directed balloon-tipped catheter advanced via the internal jugular or subclavian vein through the right atrium, right ventricle, and pulmonary artery into a terminal pulmonary capillary branch.

Thermodilution Technique & Stewart-Hamilton Equation

• Principle: A known volume (typically 10 mL) of cold saline (ice-cold 0-4°C or room temperature) is rapidly injected into the right atrial lumen (proximal port). As the cold indicator mixes with warm intracardiac blood flowing through the right ventricle, blood temperature drops.
• Measurement: A thermistor at the catheter tip in the pulmonary artery continuously records the transient drop and subsequent recovery of blood temperature over time (the thermodilution washout curve).
• Stewart-Hamilton Relationship: The area under the temperature-time curve is inversely proportional to cardiac output:
  • High Cardiac Output: Cold indicator is washed through rapidly; the curve is narrow, sharp, with a small area under the curve.
  • Low Cardiac Output: Cold indicator is cleared slowly; the curve is low, prolonged, broad, with a large area under the curve.

Pulmonary Artery Wedge Pressure (PAWP / PCWP)

• Measurement: Inflation of the distal balloon (<= 1.5 mL air) allows the catheter tip to float into and occlude a small branch of the pulmonary artery, creating a static column of blood extending from the catheter tip through the pulmonary capillary bed and pulmonary veins into the left atrium.
• Physiological Representation: In the absence of pulmonary venous obstruction or severe mitral valve stenosis, PAWP equals Left Atrial Pressure (LAP), which in end-diastole (when the mitral valve is open) directly reflects Left Ventricular End-Diastolic Pressure (LVEDP), providing an estimate of left ventricular preload.
• Normal PAWP: 6 to 12 mmHg.
• Differentiating Pulmonary Edema (Cardiogenic vs Non-Cardiogenic / ARDS):
  • Cardiogenic (Hydrostatic) Pulmonary Edema: Left ventricular failure commonly raises LVEDP, LAP and PAWP; PAWP > 18 mmHg supports hydrostatic congestion. Increased pulmonary capillary hydrostatic pressure promotes alveolar fluid accumulation, but is not a stand-alone diagnostic test.
  • Non-Cardiogenic Pulmonary Edema (ARDS): Alveolar-capillary barrier breakdown mediated by severe inflammatory injury. PAWP and cardiac index vary; neither a PAWP <= 18 mmHg nor a normal cardiac index is required. Diagnose ARDS from the acute inflammatory setting, bilateral lung opacities and hypoxaemia not primarily explained by hydrostatic oedema.

Comprehensive Hemodynamic Profiles of Shock States

---

Dynamic Measures of Fluid Responsiveness vs Static CVP

Administering intravenous fluid boluses to critically ill patients is beneficial only if the patient resides on the steep ascending limb of the Frank-Starling curve (where increasing preload produces a significant increase in stroke volume and cardiac output). Giving fluids to a patient on the flat plateau limb causes harmful tissue edema, lung congestion, and worsening organ dysfunction.

The Failure of Static Preload Indicators

Extensive clinical trials prove that static measures—Central Venous Pressure (CVP) and PAWP—have zero correlation with fluid responsiveness. A CVP of 4 mmHg or 12 mmHg cannot predict whether a patient will increase cardiac output in response to fluids.

Heart-Lung Interactions in Controlled Mechanical Ventilation

Dynamic indices exploit cyclic variations in intrathoracic pressure during positive-pressure mechanical ventilation:

1. Inspiration: The ventilator pushes a tidal volume into the lungs, increasing intrathoracic pressure. This compresses the venae cavae, reducing right ventricular venous return (preload) while transiently squeezing blood out of the pulmonary vasculature into the left heart (increasing left ventricular preload). Peak LV stroke volume occurs.
2. Expiration: Intrathoracic pressure falls. The earlier reduction in right ventricular output arrives at the left ventricle 2 to 3 heartbeats later, causing a transient nadir in left ventricular end-diastolic volume, stroke volume, and arterial pulse pressure.

Dynamic Parameters: PPV and SVV

• Pulse Pressure Variation (PPV):
  • PPV = [(PPmax - PPmin) / ((PPmax + PPmin) / 2)] × 100%
• Stroke Volume Variation (SVV):
  • SVV = [(SVmax - SVmin) / ((SVmax + SVmin) / 2)] × 100%

Strict Validation Criteria (The "Rules of Dynamic Indices")

For PPV or SVV to be diagnostic, the patient MUST satisfy all four clinical criteria:

1. Controlled mechanical ventilation without spontaneous respiratory efforts (spontaneous breathing reverses intrathoracic pressure swings, invalidating PPV/SVV).
2. Tidal volume >= 8 mL/kg of ideal body weight (lung-protective ventilation at 6 mL/kg generates insufficient intrathoracic pressure changes, yielding false negatives).
3. Regular cardiac rhythm (atrial fibrillation, frequent premature contractions, or flutter cause beat-to-beat stroke volume fluctuations unrelated to respiration, completely invalidating PPV/SVV).
4. Closed chest cavity (open thoracotomy abolishes intrathoracic pressure swings).

• Diagnostic Cut-Off: A PPV > 12% to 13% or SVV > 12% to 13% reliably predicts a >= 10-15% increase in cardiac output following a 500 mL fluid challenge (high fluid responsiveness). Conversely, PPV < 9% indicates non-responsiveness.
• The Passive Leg Raise (PLR) Test: In patients with spontaneous breathing, arrhythmias, or low tidal volumes where PPV/SVV cannot be used, a Passive Leg Raise serves as a reversible "autologous fluid challenge." Tilting the patient from semi-recumbent (45° head up) to supine with legs elevated 45° autotransfuses ~300 mL of venous blood from the lower limbs. If real-time cardiac output or stroke volume rises by >= 10% within 60 to 90 seconds, the patient is fluid responsive.

---

Echocardiographic Doppler Assessment of Stroke Volume

Transthoracic and transesophageal echocardiography provide non-invasive, continuous assessments of stroke volume across the Left Ventricular Outflow Tract (LVOT).

Mathematical Derivation

Blood flowing through the circular LVOT can be modeled as an extruded cylinder of blood per cardiac contraction. The volume of this cylinder is the product of its cross-sectional area and the distance the column moves:

SV = Area_LVOT × VTI_LVOT

Where:

• Area_LVOT = π × r² = π × (D_LVOT / 2)² = (π / 4) × D_LVOT² ≈ 0.785 × D_LVOT²
• D_LVOT: Diameter of the LVOT measured in the parasternal long-axis view at mid-systole from inner-edge to inner-edge at the base of the aortic valve leaflets (in cm).
• VTI_LVOT: Velocity-Time Integral, measured using pulsed-wave (PW) Doppler placed in the LVOT from the apical 5-chamber view. VTI represents the area under the spectral Doppler velocity envelope and corresponds to the physical distance (in cm) that blood travels during systole (normal ~18-22 cm).

SV = (0.785 × D_LVOT²) × VTI_LVOT

Worked Clinical Example

Clinical Data:

• Measured LVOT Diameter (D_LVOT) = 2.0 cm
• Pulsed-wave Doppler LVOT VTI = 20.0 cm
• Heart Rate = 75 bpm

Step 1: Calculate LVOT Cross-Sectional Area:

• Area_LVOT = 0.785 × (2.0)² = 0.785 × 4.0 = 3.14 cm²

Step 2: Calculate Stroke Volume (SV):

• SV = 3.14 cm² × 20.0 cm = 62.8 mL

Step 3: Calculate Cardiac Output (CO):

• CO = SV × HR = 62.8 mL × 75 bpm = 4,710 mL/min = 4.71 L/min

---

Systematic Arterial Blood Gas (ABG) Analysis

Arterial blood gas analysis is an essential diagnostic measurement evaluating gas exchange and acid-base equilibrium. Clinicians must apply a rigorous, 5-step analytical methodology:

Step 1: Assess Oxygenation & Gas Exchange

• PaO2 & SaO2: Evaluate arterial partial pressure of oxygen (PaO2; normal 80-100 mmHg on room air) and saturation (SaO2 > 95%).
• Horovitz Ratio (PaO2/FiO2): Standardized metric of alveolar-capillary oxygenation efficiency (normal room air PaO2/FiO2 = 95 / 0.21 ≈ 450 mmHg):
  • Berlin Definition of ARDS (with PEEP >= 5 cmH2O):
    • Mild ARDS: PaO2/FiO2 201 to 300 mmHg.
    • Moderate ARDS: PaO2/FiO2 101 to 200 mmHg.
    • Severe ARDS: PaO2/FiO2 <= 100 mmHg.

Step 2: Determine Systemic Acidity (pH)

• Normal arterial pH = 7.35 to 7.45 (corresponds to [H+] 35 to 45 nmol/L).
• Acidemia: pH < 7.35.
• Alkalemia: pH > 7.45.

Step 3: Identify the Primary Disturbance

• Metabolic: If the deviation in serum bicarbonate ([HCO3-], normal 22-26 mEq/L) parallels the direction of pH change:
  • Low pH + Low [HCO3-] = Primary Metabolic Acidosis.
  • High pH + High [HCO3-] = Primary Metabolic Alkalosis.
• Respiratory: If the deviation in partial pressure of carbon dioxide (PaCO2, normal 35-45 mmHg) is reciprocal to pH:
  • Low pH + High PaCO2 = Primary Respiratory Acidosis.
  • High pH + Low PaCO2 = Primary Respiratory Alkalosis.

Step 4: Calculate Expected Physiological Compensation

The human body never overcompensates. If actual compensation falls outside the calculated expected range, a mixed acid-base disorder is present.

1. Metabolic Acidosis -> Respiratory Compensation (Winter's Formula):
   • Expected PaCO2 = (1.5 × [HCO3-]) + 8 ± 2
   • If actual PaCO2 > expected: Concurrent respiratory acidosis (ventilatory failure).
   • If actual PaCO2 < expected: Concurrent respiratory alkalosis (hyperventilation).
2. Metabolic Alkalosis -> Respiratory Compensation:
   • Expected PaCO2 = (0.7 × [HCO3-]) + 20 ± 1.5 (or ΔPaCO2 = 0.7 × Δ[HCO3-])
3. Acute Respiratory Acidosis (uncompensated renal retention):
   • For every 10 mmHg rise in PaCO2 above 40, [HCO3-] rises by 1 mEq/L; pH drops by 0.08.
4. Chronic Respiratory Acidosis (renal tubular compensation established over 3-5 days):
   • For every 10 mmHg rise in PaCO2 above 40, [HCO3-] rises by 3.5 to 4 mEq/L; pH drops by 0.03.
5. Acute Respiratory Alkalosis:
   • For every 10 mmHg drop in PaCO2 below 40, [HCO3-] drops by 2 mEq/L; pH rises by 0.08.
6. Chronic Respiratory Alkalosis:
   • For every 10 mmHg drop in PaCO2 below 40, [HCO3-] drops by 5 mEq/L; pH rises by 0.03.

Step 5: Calculate Serum Anion Gap & Delta Ratio

In every patient presenting with metabolic acidosis, calculate the Serum Anion Gap (AG):

AG = [Na+] - ([Cl-] + [HCO3-]) (Normal: 10 to 12 mEq/L)

• Albumin Correction: Serum albumin is the predominant circulating unmeasured anion. Each 1.0 g/dL drop in serum albumin below normal (4.0 g/dL) decreases the baseline anion gap by 2.5 mEq/L. In hypoalbuminemic ICU patients, an uncorrected anion gap appears falsely normal, concealing a lethal high anion gap acidosis! Always calculate:

  • Corrected AG = Observed AG + 2.5 × (4.0 - Albumin in g/dL)

• High Anion Gap Metabolic Acidosis (HAGMA): AG > 12 mEq/L. Mnemonic GOLD MARK:

  • G: Glycols (ethylene glycol, propylene glycol)
  • O: Oxoproline (chronic paracetamol/acetaminophen abuse in malnourished females)
  • L: L-lactic acidosis (hypoperfusion, shock, sepsis, metformin)
  • D: D-lactic acidosis (short bowel syndrome)
  • M: Methanol (toxic alcohol intoxication; optic disc hyperemia)
  • A: Aspirin / Salicylates (mixed early respiratory alkalosis + late HAGMA)
  • R: Renal failure / Uremia (sulfates, phosphates)
  • K: Ketoacidosis (Diabetic [DKA], Alcoholic [AKA], Starvation)

• Normal Anion Gap Metabolic Acidosis (NAGMA / Hyperchloremic): AG = 10 to 12 mEq/L. Loss of bicarbonate is compensated by retention of chloride. Mnemonic USED CARP:

  • U: Ureterosigmoidostomy
  • S: Saline resuscitation (large volumes of 0.9% Normal Saline; Cl- = 154 mEq/L)
  • E: Early renal failure
  • D: Diarrhea (massive lower gastrointestinal loss of HCO3-)
  • C: Carbonic anhydrase inhibitors (acetazolamide)
  • A: Acid ingestion (ammonium chloride)
  • R: Renal Tubular Acidosis (RTA Type 1 distal, Type 2 proximal, Type 4 hyperkalemic)
  • P: Pancreatic fistulas or biliary drainage

• The Delta Ratio (Delta-Delta, ΔAG / ΔHCO3-): Assesses whether the increase in anion gap matches the fall in bicarbonate:

  • Delta Ratio = ΔAG / ΔHCO3- = (AG - 12) / (24 - [HCO3-])
  • < 0.4: Predominantly normal anion gap metabolic acidosis.
  • 0.4 to 0.8: Mixed HAGMA and NAGMA (bicarbonate has fallen much more than the anion gap has risen; e.g., DKA complicated by severe diarrhea or saline resuscitation).
  • 0.8 to 2.0: Predominantly High Anion Gap Metabolic Acidosis (typical of uncomplicated DKA or lactic acidosis).
  • > 2.0: Mixed HAGMA and Metabolic Alkalosis (or pre-existing chronic compensated respiratory acidosis; bicarbonate is higher than expected, e.g., DKA with severe vomiting).

---

Pulmonary Function Testing (PFTs): Spirometry & DLCO

Pulmonary function tests objectively quantify ventilatory mechanics, lung volumes, and alveolar gas exchange capacity.

Spirometry: Volumes & Discriminators

• Forced Vital Capacity (FVC): Maximum volume of air exhaled with maximal effort after full inspiration.
• Forced Expiratory Volume in 1 Second (FEV1): Volume exhaled during the first second of forceful expiration.
• FEV1/FVC Ratio (Tiffeneau-Pinelli Index): The single most important diagnostic discriminator in spirometry (interpret against the lower limit of normal [LLN]; GOLD uses post-bronchodilator < 0.70 for COPD diagnosis).

• Bronchodilator Reversibility Testing: Spirometry is repeated 15 minutes after administering 4 puffs (400 mcg) of inhaled salbutamol. For adults with typical asthma symptoms, GINA uses an increase in FEV1 or FVC of >= 12% AND >= 200 mL from baseline to support asthma. ATS/ERS laboratory criteria use > 10% of the predicted value. A response can occur in COPD, and its absence on one test does not exclude asthma; reversibility alone does not distinguish them.
• Confirmation of Restrictive Lung Disease: Spirometry showing reduced FVC with a normal FEV1/FVC ratio is suggestive of restriction, but never diagnostic on its own (severe air trapping in COPD can reduce FVC). Restriction requires TLC below its LLN, measured with an appropriate lung-volume technique, such as body plethysmography.

Diffusing Capacity of the Lung for Carbon Monoxide (DLCO)

DLCO measures the transfer of inhaled carbon monoxide across the alveolar-capillary membrane into red blood cell hemoglobin (normal: 80% to 120% predicted). It serves as the ultimate anatomical discriminator between parenchymal tissue destruction and chest wall/neuromuscular pathology:

+-----------------------------------------------------------------------------------------+
|                        DLCO CLINICAL DISCRIMINATION MATRIX                              |
+-----------------------------------------------------------------------------------------+
| RESTRICTIVE PATTERN (TLC < LLN):                                                        |
| 1. LOW DLCO (< 80%): Intrinsic Parenchymal Lung Disease                                 |
|    - Idiopathic Pulmonary Fibrosis (IPF), Sarcoidosis, Asbestosis, Pneumoconiosis       |
| 2. NORMAL DLCO (>= 80%): Extrinsic Chest Wall or Neuromuscular Disease                  |
|    - Myasthenia Gravis, Guillain-Barre, ALS, Kyphoscoliosis, Morbid Obesity             |
+-----------------------------------------------------------------------------------------+
| OBSTRUCTIVE PATTERN (FEV1/FVC < LLN; COPD uses post-BD < 0.70):                                                  |
| 1. LOW DLCO (< 80%): Emphysema (destruction of alveolar-capillary surface area)         |
| 2. NORMAL OR HIGH DLCO: Bronchial Asthma (intact alveoli; increased capillary volume)   |
+-----------------------------------------------------------------------------------------+
| ISOLATED LOW DLCO (Normal Spirometry & Normal Lung Volumes):                            |
| - Pulmonary Arterial Hypertension (PAH), Chronic Thromboembolic Disease (CTEPH), Anemia|
+-----------------------------------------------------------------------------------------+